Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

Inclusion Criteria: * Participant provides written informed consent before any study-specific evaluation is performed. * Participant is a healthy adult male or female volunteer between the ages of 18 and 45 years, inclusive, at Screening. * Participant has a body mass index of 18 to 30 kg/m2, inclusive, at Screening. * Participant meet all other inclusion criteria outlined in the clinical study protocol. Exclusion Criteria: * Participant has clinically significant abnormalities at Screening or at Check-in assessments, in the opinion of the investigator. * Participant is pregnant or breastfeeding or intends to become pregnant within 30 days after the last dose of study drug. * Participant meets any other exclusion criteria outlined in the clinical study protocol.